CRIZANLIZUMAB (KRIZ an LIZ ue mab) prevents the symptoms of sickle cell disease, such as pain crises and acute chest syndrome. It works by preventing blood cells from clumping together. This increases blood flow and the amount of oxygen that gets to your tissues. It is a monoclonal antibody.

There is no lifestyle interaction information available for this medication.